AUGS Statement on Anticholinergic Medications for Overactive Bladder and Dementia Risk

AUGS Statement on Anticholinergic Medications for Overactive Bladder and Dementia Risk

Overactive bladder (OAB) is clinically diagnosed by symptoms of urinary urgency/urge incontinence, frequency and usually nocturia. Several studies have raised concerns about the role of anticholinergic medications in cognitive decline, dementia and Alzheimer s disease. The risk was highest in patients taking the drugs with the most anticholinergic activity.

  • Provider:Postgraduate Institute for Medicine
  • Activity Link: https://www.obgproject.com/2017/07/20/augs-statement-anticholinergic-medications-overactive-bladder-dementia-risk/
  • Start Date: 2024-05-28 05:00:00
  • End Date: 2024-05-28 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.2 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.